Need a specific person's email?
Browse Ncardia's employee directory (about 42 employees) and reveal verified emails free.
Ncardia's most common email format is First.Last@ncardia.com (ex. John.Doe@ncardia.com), used for 89% of ncardia.com addresses. Ncardia uses 4 email patterns.
| Format | Example | Share of ncardia.com |
|---|---|---|
| First.Last@ncardia.comMost common | John.Doe@ncardia.com | |
| First.MiddleLast@ncardia.com | John.MichaelDoe@ncardia.com | |
| FirLast@ncardia.com | JohDoe@ncardia.com | |
| First@ncardia.com | John@ncardia.com |
Browse Ncardia's employee directory (about 42 employees) and reveal verified emails free.
Biotechnology ResearchSouth Holland, Netherlands11-50 Employees
Ncardia is a biotechnology company based in Leiden, Netherlands, specializing in drug discovery and human induced pluripotent stem cell (iPSC) technology. It operates across Europe and North America, collaborating with biopharmaceutical companies to apply stem cell-derived models at any development stage and across multiple modalities. The company has built expertise to differentiate, manufacture, and characterize iPSC-derived cells and disease models, enabling disease modeling and high-throughput screening to support drug discovery. It emphasizes listening to customer plans and co-developing iPSC-based solutions tailored to specific project requirements. A notable recent development is the 2025 launch of Ncyte NHP-C vCardiomyocytes, the first commercially available ventricular-like cardiomyocytes derived from iPSCs of cynomolgus monkeys.
Most common format
First.Last@ncardia.com
Example: John.Doe@ncardia.com
Free with a LeadIQ account. No credit card.
Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.